Skip to main content
GL Pharm Tech Corp. logo

GL Pharm Tech Corp. — Investor Relations & Filings

Ticker · 204840 ISIN · KR7204840003 KO Manufacturing
Filings indexed 264 across all filing types
Latest filing 2026-05-19 Proxy Solicitation & In…
Country KR South Korea
Listing KO 204840

About GL Pharm Tech Corp.

http://www.glpt.co.kr/

GL Pharm Tech Corp. is a pharmaceutical company specializing in the development of incrementally modified drugs (IMDs). The company focuses on creating improved versions of existing pharmaceutical products by utilizing advanced drug formulation and delivery technologies. Its core mission is to enhance the therapeutic value and safety of marketed drugs, with a specific emphasis on reducing side effects and improving patient convenience. GL Pharm Tech is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials to support the commercialization of its enhanced pharmaceutical products.

Recent filings

Filing Released Lang Actions
주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a formal notice of convening a shareholders’ meeting (임시주주총회) including date, time, venue, record date, agenda items, and related disclosures. This is a proxy/meeting solicitation document sent to shareholders to inform them of the meeting and request votes. Therefore, it falls under Proxy Solicitation & Information Statement (PSI).
2026-05-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 82% confidence The document is a corporate announcement in Korean setting the shareholder register closure period and record date for an extraordinary general meeting. It does not contain financial statements or detailed report data, nor is it announcing dividends, share issues, or management changes. This type of regulatory corporate action announcement falls under the general Regulatory Filings category.
2026-05-19 Korean
주식병합결정
Share Issue/Capital Change Classification · 90% confidence The document is a company announcement detailing the decision to consolidate its shares (reverse stock split), including pre- and post-consolidation ratios, schedule of shareholder meeting, effective dates, and the purpose of the consolidation. This falls under announcements of capital structure changes (stock splits or consolidations). It is not a full financial report but a specific capital change notice. Hence, it matches the Share Issue/Capital Change category.
2026-05-19 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제13기 1분기)” covering 2026-01-01 to 2026-03-31 and contains extensive actual financial and operational data, tables of sales, production, subsidiaries, capital changes, etc. It is the full quarter report itself, not an announcement of publication or mere summary. This matches the definition of an Interim / Quarterly Report. Q1 2026
2026-05-13 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” (Annual General Meeting Results) and provides detailed voting outcomes for each agenda item (approval of financial statements, directors’ remuneration limit, auditor’s remuneration limit), including voting percentages and pass/fail status. It also lists record date, meeting date, and related disclosures. This matches a Declaration of Voting Results & Voting Rights Announcement.
2026-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from a Korean company (GL PharmTech) announcing the submission of its audit report. It contains key financial highlights, audit opinions, and financial statements for the fiscal year. While it provides financial data, it is a summary announcement of the audit report submission rather than the full, multi-page audited financial statement document itself. Therefore, it fits the definition of a Report Publication Announcement (RPA). FY 2025
2026-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.